Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
Most Trending
TipsWhisperTipsWhisp is an investment enthusiast sharing actionable tips and insights. Focused on market trends, TipsWhisp delivers concise content to empower smarter decision-making in the stock market.
02 Oct 2025$GBDC is recovering from deeply oversold levels, with RSI climbing from 25 to 33. The stock bounced off support at $13.51 with above-average volume, but recent concerns about thin dividend coverage could limit upside. Needs to clear $14.81 resistance to confirm sustained reversal.
$ABEO Abeona is emerging from oversold conditions with a catalyst-driven narrative. The Zevaskyn® commercial launch with first patient treatment expected in Q3 2025 provides fundamental support to the technical setup. Volume has surged 38% above average, suggesting accumulation. Support at $5.28 offers a tight 2.6% stop-loss reference, while resistance at $7.23 represents 33% upside potential.
$NMFC New Mountain presents the most conservative play with textbook oversold bounce behavior. The tight trading range between $9.48 support and $9.92 resistance creates clear boundaries. As a BDC, NMFC exhibits lower volatility, appealing to conservative traders, though upside is limited to 3.4% to resistance.
$TRON Tron exploded +24.88% in a single session, launching RSI from 23 to 35. Volume more than doubled average levels, but the lack of news raises questions about sustainability. Already 27% off support, the stock may face profit-taking despite 52% theoretical upside to resistance.
$SNGX Soligenix closed a $7.5 million public offering on September 29 while expanding its European Medical Advisory Board. RSI barely cleared oversold territory at 30.57, suggesting early-stage rebound. Volume tripled the average with +6.85% gains. Support at $1.11 provides a 16.5% cushion, while resistance implies 162% upside, the largest in this group.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
